Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2022-06-17 | 2022-07-28 | 162907 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-07-15 | 2023-01-20 | 164719 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-15 | 2022-08-06 | 164728 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-09-30 | 2023-01-20 | 170766 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2022-11-11 | 2023-01-20 | 174359 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2023-02-16 | 2023-05-19 | 185007 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2023-02-16 | 2023-05-06 | 185010 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-12-06 | 2024-03-08 | 212569 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2024-02-09 | 2024-03-08 | 219156 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-08-22 | 2024-11-08 | 235695 |
| APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2025-05-01 | 2025-08-22 | 256319 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2025-06-12 | 2025-07-18 | 260153 |
| APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2025-07-03 | 2025-07-18 | 261626 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Actual shortage | 2025-05-15 | 2025-07-31 | 257519 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Resolved | 2025-05-15 | 2025-07-18 | 257525 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260156 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-12 | 2025-08-22 | 260159 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260162 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
| APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60766 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
| APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60772 |
| APO-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60775 |
| APO-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2019-02-05 | 60778 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SERTRALINE | 100MG | CAPSULE | Discontinued | 2018-09-08 | 2018-09-15 | 60781 |
| APO-SILDENAFIL | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60784 |
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-SIMVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60790 |
| APO-SIMVASTATIN | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-11-19 | 60793 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |